Correction: Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report

被引：0

作者：

Hirokazu Takami

Akitake Mukasa

Shunsaku Takayanagi

Tsukasa Koike

Reiko Matsuura

Masako Ikemura

Tetsuo Ushiku

Gakushi Yoshikawa

Junji Shibahara

Shota Tanaka

Nobuhito Saito

机构：

[1] The University of Tokyo Hospital,Departments of Neurosurgery

[2] Kumamoto University Hospital,Department of Neurosurgery

[3] The University of Tokyo Hospital,Department of Pathology

[4] Showa General Hospital,Department of Neurosurgery

[5] Kyorin University Hospital,Department of Pathology

来源：

Brain Tumor Pathology | 2023年 / 40卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：142 / 142

共 50 条

[31] Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience
Frenel, J. S.
Leux, C.
Loussouarn, D.
Le Loupp, A. -G.
Leclair, F.
Aumont, M.
Mervoyer, A.
Martin, S.
Denis, M. G.
Campone, M.
JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (01) : 85 - 91
[32] Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience
J. S. Frenel
C. Leux
D. Loussouarn
A.-G. Le Loupp
F. Leclair
M. Aumont
A. Mervoyer
S. Martin
M. G. Denis
M. Campone
Journal of Neuro-Oncology, 2013, 114 : 85 - 91
[33] The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients
Hacisalihoglu, Payam
Kucukodaci, Zafer
Gundogdu, Gokcen
Bilgic, Bilge
TURKISH NEUROSURGERY, 2017, 27 (05) : 682 - 689
[34] IDH1 and IDH2 Mutations Correlations with Histology and 1p/19q Codeletion in 309 Gliomas
Nafa, K.
Yilmaz, I.
Shukla, N.
Jhanwar, S. C.
Huse, J. T.
Ladanyi, M.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 904 - 904
[35] Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas
Godraind, C
Rousseau, E
Ruchoux, MM
Scaravilli, F
Vikkula, M
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (05) : 462 - 471
[36] Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry
Hermelo, Ismail
Haapala, Ilkka
Makela, Meri
Sanz, Dafne Jacome
Kontunen, Anton
Karjalainen, Markus
Muller, Philipp
Lehtimaki, Kai
Nykter, Matti
Frosen, Juhana
Haapasalo, Hannu
Roine, Antti
Oksala, Niku
Nordfors, Kristiina
Vehkaoja, Antti
Haapasalo, Joonas
JOURNAL OF NEURO-ONCOLOGY, 2025, 171 (03) : 691 - 703
[37] A "Weighted" Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors
Senetta, Rebecca
di Cantogno, Ludovica Verdun
Chiusa, Luigi
Castellano, Isabella
Gugliotta, Patrizia
Sapino, Anna
Cassoni, Paola
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (05): : 432 - 441
[38] Outcome and evaluation of 1p and 19q deletion by chromogenic in situ hybridization (CISH) in patients with diagnosis of oligodendroglioma (OD) and oligoastrocitoma (OA)
Rafael Bella, Santiago
Roberto Llugdar, Jose
Lingua, Alejo
Alejandro Theaux, Ricardo
Papalini, Francisco
Olocco, Ricardo
Lerda, Daniel
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[39] Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas
Iwamoto, Fabio M.
Nicolardi, Linda
Demopoulos, Alexis
Barbashina, Violetta
Salazar, Paulo
Rosenblum, Marc
Hormigo, Adilia
JOURNAL OF NEURO-ONCOLOGY, 2008, 88 (03) : 293 - 298
[40] Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas
Fabio M. Iwamoto
Linda Nicolardi
Alexis Demopoulos
Violetta Barbashina
Paulo Salazar
Marc Rosenblum
Adília Hormigo
Journal of Neuro-Oncology, 2008, 88 : 293 - 298

← 1 2 3 4 5 →